CS561386A2 - Zpusob vyroby krystalickeho sovatu - Google Patents

Zpusob vyroby krystalickeho sovatu

Info

Publication number
CS561386A2
CS561386A2 CS865613A CS561386A CS561386A2 CS 561386 A2 CS561386 A2 CS 561386A2 CS 865613 A CS865613 A CS 865613A CS 561386 A CS561386 A CS 561386A CS 561386 A2 CS561386 A2 CS 561386A2
Authority
CS
Czechoslovakia
Prior art keywords
sovatu
krystalickeho
zpusob vyroby
vyroby
zpusob
Prior art date
Application number
CS865613A
Other languages
English (en)
Other versions
CS258143B2 (en
Inventor
Leonard B Crast Jr
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CS561386A2 publication Critical patent/CS561386A2/cs
Publication of CS258143B2 publication Critical patent/CS258143B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
CS865613A 1985-07-29 1986-07-24 Method of crystalline solavate production CS258143B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/759,805 US4694079A (en) 1985-07-29 1985-07-29 3-propenyl cephalosporin solvates

Publications (2)

Publication Number Publication Date
CS561386A2 true CS561386A2 (en) 1987-09-17
CS258143B2 CS258143B2 (en) 1988-07-15

Family

ID=25057020

Family Applications (1)

Application Number Title Priority Date Filing Date
CS865613A CS258143B2 (en) 1985-07-29 1986-07-24 Method of crystalline solavate production

Country Status (17)

Country Link
US (1) US4694079A (cs)
KR (1) KR930004014B1 (cs)
CN (1) CN1015263B (cs)
AR (1) AR243530A1 (cs)
AT (1) AT389876B (cs)
CA (1) CA1262345A (cs)
CS (1) CS258143B2 (cs)
DD (1) DD248594A5 (cs)
EG (1) EG18112A (cs)
ES (1) ES2001338A6 (cs)
FI (1) FI84269C (cs)
GR (1) GR861988B (cs)
HU (1) HU195224B (cs)
NO (1) NO167461C (cs)
PT (1) PT83074B (cs)
SU (1) SU1414317A3 (cs)
YU (1) YU45350B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128336A (en) * 1988-03-23 1992-07-07 Eli Lilly And Company 3-(substituted)-1-carba(dethia)-3-cephems
DK0630380T3 (da) * 1992-02-05 2001-12-10 Biochemie Gmbh Fremgangsmåde til rensning af et 3-cephem-4-carboxylsyrederivat
AT399876B (de) * 1992-02-05 1995-08-25 Biochemie Gmbh Verfahren zur abreicherung von 7-amino-3-((e)-1- propen-1-yl)-3-cephem-4-carbonsäure
PT102061B (pt) * 1997-10-08 2000-06-30 J K Ind Ltd Processo de preparacao de um antibiotico cefalosporina geralmente activo-cefixime
WO2001023393A1 (en) * 1999-09-30 2001-04-05 Otsuka Kagaku Kabushiki Kaisha 3-cephem derivative crystal and method for preparing the same
KR100408430B1 (ko) * 2001-04-18 2003-12-06 한미약품 주식회사 3-(ｚ)-프로페닐 세펨 화합물의 선택적인 제조 방법
US6903211B2 (en) * 2002-10-30 2005-06-07 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of 3-propenyl cephalosporin DMF solvate
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
WO2004110399A2 (en) * 2003-06-19 2004-12-23 Ranbaxy Laboratories Limited Solvates of cefprozil
KR100576336B1 (ko) * 2003-10-30 2006-05-03 씨제이 주식회사 세팔로스포린 유도체의 제조방법
US20070072945A1 (en) * 2004-03-31 2007-03-29 Pohoreski Anton Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
ES2338335T3 (es) 2004-11-01 2010-05-06 Hetero Drugs Limited Nuevo procedimiento de preparacion de intermedio cefprozilo.
CN101058584B (zh) * 2007-05-23 2010-05-26 上海骏捷生化科技有限公司 一种制备头孢丙烯母核7-氨基-3-丙烯基头孢烷酸的方法
CN103524533B (zh) * 2013-10-10 2016-01-27 珠海金鸿药业股份有限公司 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法
CN108017658B (zh) * 2017-12-26 2020-06-16 山东裕欣药业有限公司 一种头孢丙烯的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
EP0113568B1 (en) * 1982-12-27 1990-04-04 Eli Lilly And Company Intermediates for the preparation of ceftazidine, and process for their preparation
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins

Also Published As

Publication number Publication date
PT83074A (en) 1986-08-01
GR861988B (en) 1986-12-22
CN86105568A (zh) 1987-04-01
KR930004014B1 (ko) 1993-05-19
YU131086A (en) 1987-10-31
HUT41799A (en) 1987-05-28
YU45350B (en) 1992-05-28
AR243530A1 (es) 1993-08-31
NO862970L (no) 1987-01-30
NO167461C (no) 1991-11-06
DD248594A5 (de) 1987-08-12
NO862970D0 (no) 1986-07-24
SU1414317A3 (ru) 1988-07-30
FI84269B (fi) 1991-07-31
CS258143B2 (en) 1988-07-15
NO167461B (no) 1991-07-29
ES2001338A6 (es) 1988-05-16
PT83074B (pt) 1989-06-30
FI863066A0 (fi) 1986-07-25
ATA202886A (de) 1989-07-15
EG18112A (en) 1992-08-30
CA1262345A (en) 1989-10-17
AT389876B (de) 1990-02-12
CN1015263B (zh) 1992-01-01
KR870001216A (ko) 1987-03-12
FI863066L (fi) 1987-01-30
US4694079A (en) 1987-09-15
FI84269C (fi) 1991-11-11
HU195224B (en) 1988-04-28

Similar Documents

Publication Publication Date Title
BG47969A1 (en) Cryoultrasonic skalpel
CS561386A2 (en) Zpusob vyroby krystalickeho sovatu
AR242568A1 (es) Un procedimiento para la preparacion de compuestos derivados del 1-carboxi-3,4-metilendioxi-fenantreno-8-sustituido.
CS1007585A1 (en) Pruzna spojka
CA54278S (en) Footbag
CA54277S (en) Footbag
CA54075S (en) Footbag
CA54057S (en) Mini-kiosk
CS1008585A1 (en) Regeneracni ohrivak
CS1010985A1 (en) Zapojeni zesilovace vychylovaciho proudu
BG40775A1 (en) Batometer
BG42308A1 (en) Semiluminometer
BG45815A1 (en) Dust- concentrator
BG40551A1 (en) Accelerator- plasticizer
BG48049A1 (en) Hydroimpulser
BG40359A1 (en) Vibroseparator
BG39630A1 (en) Video- compressor
AU96933S (en) Kitchenmachine
AU94798S (en) Flowerglass
CS100185A1 (en) Zpusob emulgace vodonerozpustnych barvotvornych slozek
CS1002385A1 (en) Aerodynamicky kryt zubovych vybrani rotoru
CS1004285A1 (en) Radialne diagonalni michadlo
CS1005085A1 (en) Zdravotna obuv
CS113185A1 (en) Odlucovac kapalnych aerosolu
CS111685A1 (en) Elektroluminiscencni pruhledovy orotogonalne graficky displej

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20010724